Application of sodium-glucose cotransporter 2 inhibitors in acute myocardial infarction
- Author:
Xiao HAO
1
;
Mei ZHAO
1
;
Wenjing WANG
1
;
Feifei ZHANG
1
;
Huiliang LIU
1
;
Yi DANG
1
;
Shuren LI
1
;
Xiaoyong QI
1
Author Information
- Publication Type:Journal Article
- Keywords: acute myocardial infarction; heart failure; sodium-dependent glucose transporters 2 inhibitors; ventricular remodeling
- From: Chinese Journal of Clinical Pharmacology and Therapeutics 2023;28(7):824-831
- CountryChina
- Language:Chinese
- Abstract: SGLT2 inhibitors currently have clear benefits in the treatment of heart failure whether combined with diabetes or not. Ventricular remodeling after myocardial infarction leads to the occurrence and development of heart failure, and eventually leads to death. There are relatively few studies on SGLT2 inhibitors in patients with myocardial infarction. The purpose of this article is to review the research progress of SGLT2 inhibitors application before and after myocardial infarction.
